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Abstract Lecithin retinol acyl transferase (LRAT) is a novel
membrane bound enzyme that catalyzes the formation of
retinyl esters from vitamin A and lecithin. The enzyme is both
essential for vision and for the general mobilization of vitamin A.
The sequence of LRAT defines it as a novel enzyme unrelated to
any other protein of known function. LRAT possesses a
catalytically essential active site cysteine residue. The enzyme
also contains six histidine residues. It is shown here that two of
these residues (H57 and H163) are essential for catalysis. A
mechanistic hypothesis is presented to account for these obser-
vations. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Lecithin retinol acyl transferase (LRAT) is a novel mem-
brane bound enzyme central to the processing of vitamin A in
the visual system and in peripheral tissues [1^5]. The enzyme
catalyzes a reversible transesteri¢cation reaction involving vi-
tamin A and phosphatidylcholine (lecithin) by a ping-pong
mechanism [6] (Scheme 1). LRAT is central for vision because
the product of LRAT processing, all-trans-retinyl esters, are
substrates along the pathway to 11-cis-retinol (al), the chro-
mophore of rhodopsin [7,8]. LRAT is also generally impor-
tant for the formation of retinyl esters in general vitamin A
storage and mobilization processes [3,4].
While LRAT has never been fully puri¢ed, it can be specif-
ically a⁄nity labeled with electrophilic reagents, which led to
its identi¢cation and partial sequencing [9]. The complete se-
quence of human LRAT has been determined by cloning
based on the identi¢ed sequences [10]. The 25.3 kDa (calcu-
lated) protein is entirely novel, and showed only limited ho-
mology to a small group of proteins of unknown function
[10]. The mechanism of action of LRAT is likely to be inter-
esting, in as much as LRAT does not show any homology to
enzymes that catalyze similar reactions, such as lecithin cho-
lesterol acyl transferase [11^13]. This latter enzyme, which is
typical of serine acyltransferases, catalyzes the reversible acy-
lation of cholesterol with lecithin and is essential for choles-
terol mobilization [11^13]. LRAT, of course, shows none of
the motifs expected in a serine enzyme. In fact, LRAT is not
inhibited by moderate concentrations of phenylmethylsulfonyl
£uoride, a reagent known to inhibit serine-dependent enzymes
[14]. LRAT, however, is readily inactivated by thiol-directed
enzyme inhibiting reagents [9], and it has been shown to pos-
sess an active site cysteine (C161) essential for catalysis [15].
Typically, thiol-dependent enzymes in the protease/lipase
category, as LRAT is, possess additional active site residues
essential for catalysis. In the case of thiol proteases, the cata-
lytic triad involves an essential histidine residue and an essen-
tial aspartate [16]. Sometimes an asparagine residue substi-
tutes for the aspartate residue [17]. Consequently, it was of
interest to probe the possible functional roles of the six histi-
dine residues of LRAT. Histidine residues are typically in-
volved in protonation^deprotonation reactions in biochemis-
try because histidine possesses a pKA of close to 7. In the
present studies, six Q/H mutations in LRAT were prepared
and assessed for catalytic function. Of the six H residues, only
H57 and H163 proved to be essential for catalysis. The re-
maining four Q/H mutants showed activities approximating
or exceeding wild-type (WT) LRAT activity. A mechanism
involving the two histidines in catalysis is presented.
2. Materials and methods
2.1. Materials
Frozen bovine eye cups were obtained from W.L. Lawson Co.
(Lincoln, NE, USA). [11,12-3H,3H]All-trans-retinol (31.4 Ci/mmol)
was obtained from NEN Life Sciences. L-K-Dipalmitoylphosphatidyl-
choline (DPPC), bovine serum albumin (BSA), dithiothreitol (DTT),
all-trans-retinyl palmitate, and protein A were from Sigma. Triton X-
100 was from Calbiochem. High performance liquid chromatography
(HPLC) grade solvents were obtained from J.T. Baker. The enhanced
chemiluminescence Western blotting kit was from Amersham. All
other reagents were of analytical grade.
2.2. Methods
2.2.1. Solubilization of WT and mutant LRAT activity in deter-
gents. The WT and mutant LRAT proteins were solubilized in de-
tergent containing Tris^HCl bu¡er. Brie£y, the procedure involved
incubation of 5 Wl of cell suspension with 0.4% TX-100 in a 100
mM Tris^HCl bu¡er medium at pH 8.3. The cell suspensions contain-
ing detergent were gently agitated with the help of a continuous rotat-
ing device. All incubations were performed at 4‡C for at least 2 h.
Finally, the reaction mixture was centrifuged at 2000 rpm at 4‡C for
2^5 min. The supernatant containing solubilized LRAT protein was
collected and used for further kinetic analysis. The solubilized protein
retains full activity for several days when stored at 370‡C.
2.2.2. Steady-state kinetics. The kinetic experiments for LRAT
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activity were performed using solubilized enzyme by monitoring the
formation of LRAT catalyzed retinyl esters from all-trans-retinol and
DPPC. All procedures for the kinetic experiments were performed
following the previously reported method [15] with slight modi¢ca-
tions of reaction conditions. The incubation and reactions were car-
ried out under dim red light at room temperature. All-trans-retinol
[11,12-3H2] was dissolved in dimethyl sulfoxide (DMSO) in a range of
concentrations to make various stock solutions. 1 Wl of these stock
solutions in DMSO was added to a 100 Wl total bu¡er volume con-
taining membrane suspension, DPPC, BSA, EDTA and DTT. The
¢nal concentrations of the components in the reaction mixtures are
100 mM Tris^HCl at pH 8.3, 220 WM DPPC, 0.6% BSA, 1 mM
EDTA, 2 mM DTT, a varying concentration of all-trans-retinol and
a desired amount of protein. The reactions were performed at room
temperature for a certain length of time that depends on the speci¢c
activity of WT and mutant LRATs. The reactions were quenched by
the addition of 500 Wl of methanol, 100 Wl of H2O was added, and 500
Wl hexane (containing butylated hydroxy toluene at 1 mg/ml) was used
to extract the retinoids. The retinoids were analyzed on a PVA-Sil
(250U4.0, YMC) HPLC column using 7% dioxane in hexane as
eluant at a £ow rate of 1.5 ml/min. Radioactivity was counted with
an online Berthold LB 506-C HPLC radioactivity monitor interfaced
with an IBM computer. All experiments were performed in duplicate.
The average values from these measurements were used for analysis.
The initial rates of formation of retinyl ester products (catalyzed by
WT and mutant proteins) were normalized with respect to the relative
expression amounts of LRAT proteins as observed from the Western
blotting analysis of solubilized WT and mutant samples. Therefore,
these reaction rates provide a convenient method to compare the rel-
ative activity of WT and other mutant proteins. Protein concentra-
tions were determined using Bradford method using a Bio-Rad pro-
tein assay kit.
2.2.3. Site-directed mutagenesis. Site-directed mutagenesis was
performed by overlap extension using the polymerase chain reaction
(PCR) procedure originally described by Ho et al. [18]. This method-
ology was previously used for the generation of several cysteine-
LRAT mutants [15].
In order to mutate the six di¡erent histidines (H) in the LRAT
polypeptide into glutamine (Q), di¡erent sets of forward (F) and re-
verse (R) primers were designed from the published human LRAT
sequence [10] as shown in Table 1. A WT human LRAT construct
described previously [10] was used as a positive control for the induc-
tion of LRAT activity in transfection experiments and as a template
for the generation of mutants by PCR ampli¢cation. PCR experi-
ments were performed according to the vendor’s instructions provided
in the GeneAmp PCR core reagents (Perkin-Elmer) and the ampli¢-
cations were carried out in a Robocycler 40 apparatus (Stratagene, La
Jolla, CA, USA).
The ¢nal PCR product containing the single mutation was sub-
cloned into the pCR II vector and subsequently inserted in the unique
EcoRI site of the mammalian expression vector pcDNA3 (Invitrogen)
where expression is driven by the human cytomegalovirus promoter.
The presence of the insertion was con¢rmed by EcoRI digestion and
its correct orientation determined by double-stranded DNA sequenc-
ing with the dideoxy chain termination method [19] using the Seque-
nase 2.0 sequencing system (US Biochemical Corp.).
2.2.4. Transfection of HEK-293T cells. A human embryonic kid-
ney cell line (HEK-293T) was used to study the induction of LRAT
activity after transfection with LRAT or LRAT mutant DNA. Main-
tenance and processing of the HEK-293T cells has been previously
described in detail [20]. HEK-293T cells grown to around 80% con-
£uency in 100 mm culture plates were transfected with 30 Wg/plate of
plasmid DNA using calcium phosphate as a vehicle, according to
Kingston [21]. After 24 h of incubation transfected cells were collected
Scheme 1. LRAT catalyzed esteri¢cation of vitamin A.
Table 1
Description of oligonucleotide primers utilized for the generation of LRAT mutants
LRAT primers Primer sequences Position
5P UTR F5Ptttaccttcctctctcctcagcggc3P 359 to 335
mut H/Q 46 F5Pagctctttccagcgaggcgac3P 127^147
R5Pgtcgcctcgctggaaagagct3P 127^147
Mut H/Q 57 F5Pccccggacccagctgacccac3P 160^180
R5Pgtgggtcagctgggtccgggg3P 160^180
Mut H/Q 60 F5Pcacctgacccagtatggcatc3P 169^189
R5Pgatgccatactgggtcaggtg3P 169^189
Mut H/Q 72 F5Pcgtgttgcccagatgatgccc3P 205^225
R5Pgggcatcatctgggcaacacg3P 205^225
Mut H/Q 126 F5Pctggtcaatcagctggacgag3P 367^387
R5Pctcgtccagctgattgaccag3P 367^387
Mut H/Q 163 F5Paactgcgagcagttcgtgacc3P 478^498
R5Pggtcacgaactgctcgcagtt3P 478^498
3P UTR R5Ptacagaatacacacactgacatgggg3P 702^727
Triplet nucleotide sets replacing the histidine cac with glutamine cag are shown in bold. The nucleotide position of primer sequences is num-
bered from the atg initiation site.
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in Hanks’ balanced salt solution (Irvine Scienti¢c, Irvine, CA, USA)
and pelleted in 15 ml tubes at 1000Ug for 5 min at 4‡C. Cell pellets
were frozen at 380‡C until further analysis. A vector with no LRAT
insert was used as a negative control. Western blot analysis and a
peptide polyclonal antibody against LRAT described previously
[10], were used for the evaluation of the expression of LRAT protein
in transfected cells compared to extracts from RPE cells as a positive
control.
3. Results and discussion
LRAT contains six histidine residues (H46, H57, H60, H72,
H126 and H163), and all of these histidine residues are pre-
dicted to be in cytoplasmic regions of the integral membrane
protein [10]. The LRAT protein has already been expressed in
HEK-293 cells, which are otherwise devoid of LRAT-like ac-
Scheme 2. Mutagenesis studies on LRAT.
Scheme 3. Involvement of histidine residues in LRAT catalysis.
FEBS 24515 19-1-01
M.S. Mondal et al./FEBS Letters 489 (2001) 14^1816
tivity [10]. Previously, a series of mutations at the cysteine
residues of LRAT were prepared and studied [15]. In the
case of the histidine residues under consideration here, Q
for H substitutions for each of the six histidine residues
were prepared and expressed in HEK-293T cells. Yields of
the expressed proteins appear to be greater in HEK-293T cells
as compared to the HEK-293 variant. An illustration of
LRAT and the positions of the six histidine residues as well
as the catalytically essential C161 residue is shown in Scheme
2. The series of the six mutants studied are H72Q, H60Q,
H126Q, H46Q, H57Q and H163Q. In Fig. 1 are shown data
for WT LRAT and the H72Q mutant.
In Fig. 2 are shown data for mutants H60Q, H126Q and
H46Q. The data are summarized for these active mutants in
Table 2. Clearly, all of these mutants are active and, in fact,
H72Q is substantially more active than WT LRAT. Therefore,
H72, H60, H126 and H46 can be removed from consideration
as being either catalytically or structurally important for
LRAT action. The same is not true for H57 and H163, be-
cause both H57Q and H163Q proved to be catalytically inert.
The LRAT activities of these two mutants were indistinguish-
able from that of H293 cells transfected with empty vector
and are thus inert.
The experiments described here rule out the possibilities
that H72Q, H60Q, H126Q and H46Q are catalytically impor-
tant. H57 and H163, on the other hand, are important for
catalytic function. It is interesting to note that only these two
histidine residues are found in regions of LRAT predicted to
be K-helical. Moreover, C161 is the catalytically active thiol
group of LRAT. This cysteine residue is then quite close spa-
tially to H163. Since no structural information is available on
LRAT, the relative spatial orientation of H57 and CC161 are
unknown at present but, of course, they could be nearby in
Fig. 1. Steady-state kinetic plots for the formation of retinyl ester
products by H72Q (A) and WT (B) LRAT protein. The initial rates
of the formation of ester products were measured at increasing con-
centrations of all-trans-retinol. The DPPC concentration was 220
WM. The symbols represent the mean value of duplicate determina-
tions. The errors in the experimental data are in the range of 4^9%.
The Lineweaver^Burk plots of these initial rate experiments are
shown as insets to the ¢gure.
Table 2
The kinetic parameters for WT and mutant LRAT proteins at room
temperature





WT 0.36 þ 0.06 116 þ 6 23.2 þ 1.2
H46Q 0.1 þ 0.02 61 þ 5 8.9 þ 0.7
H60Q 1.08 þ 0.11 101 þ 6 5.0 þ 0.3
H72Q 2.4 þ 0.2 416 þ 17 31.3 þ 1.3
H126Q 0.167 þ 0.04 87 þ 5 11.4 þ 0.6
The experiments are performed as described in Section 2.
Fig. 2. Steady-state kinetic plots for the formation of retinyl ester
products by H60Q (A), H126Q (B) and H46Q (C) mutant LRAT
proteins. The initial rates of the formation of ester products were
measured at increasing concentrations of all-trans-retinol. The
DPPC concentration was 220 WM. The symbols represent the mean
value of duplicate determinations. The errors in the experimental
data are in the range of 4^9%. The Lineweaver^Burk plots of these
initial rate experiments are shown as insets to the ¢gure.
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space. A possible mechanism involving the two histidine res-
idues is provided in Scheme 3. The ping-pong kinetic mecha-
nism for LRAT indicates that a sn-1 acyl moiety of lecithin is
¢rst transferred to an active site nucleophile of LRAT, prob-
ably C161 [15]. In ensuing steps, the lysolecithin leaves and
vitamin A is bound. Finally, the acyl moiety of the acyl^en-
zyme intermediate is transferred to the vitamin A, generating
the retinyl ester [6]. Base catalysis is required in this kind of
mechanism, and the putative involvement of the two histidine
residues in base catalysis is shown in Scheme 3. One of the
histidine residues could act as a base to generate the thiolate
anion in the ¢rst step, which then reacts as the nucleophile
attacking lecithin and generating the thioacyl intermediate. In
step two, the second histidine residue could act as a general
base to help abstract the HO proton of vitamin A, thus in-
creasing its nucleophilicity and enhancing its ability to attack
the acyl enzyme intermediate (Scheme 3). The validity of this
hypothesis is currently being tested experimentally.
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